Work

Use of homologous recombination deficiency (HRD) score to enrich for niraparib sensitive high grade ovarian tumors.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.5532

Authors: Keith Matthew Wilcoxen, Marc Becker, Christopher Neff, Victor Abkevich, Joshua Timothy Jones, Xiaonan Hou, Yan Wang, Anne-Renee Hartman, Mariam M. AlHilli, Alexander Gutin, Shefali Agarwal, Kirsten Timms, Paul Haluska

Institutions: Tesaro (United States), Mayo Clinic, Myriad Genetics

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2344901254

Cites:

Cited by: 16

Related to: 10